<SEC-DOCUMENT>0001104659-18-056032-index.html : 20180910 <SEC-HEADER>0001104659-18-056032.hdr.sgml : 20180910 <ACCEPTANCE-DATETIME>20180910163155 ACCESSION NUMBER: 0001104659-18-056032 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20180723 ITEM INFORMATION: Completion of Acquisition or Disposition of Assets ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20180910 DATE AS OF CHANGE: 20180910 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics plc CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37558 FILM NUMBER: 181063124 BUSINESS ADDRESS: STREET 1: 56 FITZWILLIAM SQUARE CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: (610) 816-6640 MAIL ADDRESS: STREET 1: 1000 CONTINENTAL DRIVE STREET 2: SUITE 600 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 FORMER COMPANY: FORMER CONFORMED NAME: Nabriva Therapeutics AG DATE OF NAME CHANGE: 20150507 </SEC-HEADER> <DOCUMENT> <TYPE>8-K/A <SEQUENCE>1 <FILENAME>a18-27046_18ka.htm <DESCRIPTION>8-K/A <TEXT> Document 1 - file: a18-27046_18ka.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.3 <SEQUENCE>2 <FILENAME>a18-27046_1ex99d3.htm <DESCRIPTION>EX-99.3 <TEXT> Document 2 - file: a18-27046_1ex99d3.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.4 <SEQUENCE>3 <FILENAME>a18-27046_1ex99d4.htm <DESCRIPTION>EX-99.4 <TEXT> Document 3 - file: a18-27046_1ex99d4.htm
</DOCUMENT> </SEC-DOCUMENT>